Medindia

X

FDA News & Notes - Week of May 30, 2011

Wednesday, June 1, 2011 General News J E 4
Advertisement

SILVER SPRING, Md., May 31, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights for this week from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of May 31, 2011.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.

Meetings, Workshops, and Congressional Testimony:Tuesday, 5/31 – The Cellular, Tissue, and Gene Therapies Advisory Committee hears about research programs at the FDA's Center for Drug Evaluation and Research involving biochemistry, therapeutic proteins, molecular oncology, cell biology, and monoclonal antibodies. 2:30 p.m. to 5:15 p.m., National Institutes of Health, 29 Lincoln Drive, Building 29B, Conference Rooms A and B, Bethesda, Md.Press Office Contact: Shelly Burgess, 301-796-4651, shelly.burgess@fda.hhs.gov

Thursday, 6/2 – Center for Devices and Radiological Health Director Jeff Shuren testifies before the Subcommittee on Health Care, District of Columbia, Census and the National Archives of the House Committee on Oversight and Government Reform on "Pathway to FDA Medical Device Approval: Is there a Better Way?" 1:30 p.m., Room 2154, Rayburn House Office Building, Washington, DC.Press Office Contact: Karen Riley, 301-796-4674, karen.riley@fda.hhs.gov

Thursday, 6/2 and Friday, 6/3 – Workshop on Seizure Detection, Cognitive Function, and TBI/Concussion Devices: Issues in Their Evaluation. Discussion of approaches and endpoints for clinical studies and how results should be conveyed so that the devices may be used effectively. 8 a.m., Building 31, 10903 New Hampshire, Silver Spring, Md.Press Office Contact: Amanda Sena, 301-796-0393, amanda.sena@fda.hhs.gov

Monday, 6/6 – The FDA's third public meeting on the Food Safety Modernization Act to discuss implementation of the inspections and compliance provisions of the act. 9 a.m., 10903 New Hampshire Avenue, Building 31, Room 1503, Silver Spring, Md. Registration opens at 7:30 a.m. Seating is limited to 200. Press Office Contact: Doug Karas, 301-796-2805, douglas.karas@fda.hhs.gov

FDA Office of Public Affairs Contact Information:Call or email FDA Office of Public Affairs, 301-796-4540, fdaopa@fda.hhs.govList of FDA press officers and beats

More Resources:FDA News & Events

FDA Photos (Flickr)

Consumer Health Information

SOURCE U.S. Food and Drug Administration

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
IMD Companies, Inc. Announces OMI Operations in Fl...
S
Anthem Blue Cross Teams With APS Healthcare to Pro...